News

Clinical Trials update for February 2011

Bayer initiates a randomized Phase III trial of Regorafenib in GIST: On January 10, 2011 Bayer Healthcare in Berlin, Germany announced the initiation of a randomized phase III trial of Regorafenib (BAY 73-4506) for Gastrointestinal Stromal Tumor patients.

By |2019-12-26T14:26:51-05:00February 1st, 2011|Clinical Trials, News, Stivarga|

LRG responds to recent Cancer Cell coverage

Yesterday, there were a series of news stories reporting on an article published by Cooke et al inCancer Cell. Unfortunately, the coverage gave misleading information which could suggest that patients should not take Gleevec (imatinib) or Sutent (sunitinib).

By |2014-09-17T10:15:35-04:00January 19th, 2011|News|

Introducing…Alianza GIST!

The Latin American GIST Initiative now has a name...and a logo! Alianza GIST is a partnership of patient advocates representing ten Latin American countries and aims to improve the knowledge of patients and physicians, as [...]

By |2019-12-26T14:52:11-05:00December 1st, 2010|News|

EU Cancer Patients Concerns Heard: Cancer Patient Mobility Moves Closer to a Reality

EU Cancer Patients Concerns Heard: Cancer Patient Mobility Moves Closer to a Reality. The following article was taken from a European Cancer Patient Coalition press release. A “yes” vote in the European Parliament’s public health committee [on October 27, [...]

By |2019-12-26T14:48:04-05:00December 1st, 2010|News|

No guilt for charitable giving through iGive and Goodshop

This holiday season, ditch the guilt of spending and make a purchase that combines the good feelings of giving and charitable giving by shopping online through iGive.com and Goodshop.com. With partnerships from over 1,500 popular stores on both [...]

By |2019-12-26T14:43:40-05:00December 1st, 2010|Fundraising, News|
Go to Top